Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrative Sequencing In Germline and Hereditary Tumours

NCT03857594 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT03857594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03857594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrative Sequencing In Germline and Hereditary Tumours
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Active, not recruiting
Start date
October 2, 2018
Completion date
September 30, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

germline mutation, hereditary cancer syndrome, high-risk, mutation